Connect with us

International

US Court Jails Ketamine Supplier Linked to Matthew Perry’s Death

Published

on

Share

 

A woman at the center of the drug supply chain that led to the death of Matthew Perry has been sentenced to 15 years in federal prison, marking a significant development in a case that shocked Hollywood and fans worldwide.

Jasveen Sangha, a Los Angeles resident described by prosecutors as a high-level ketamine dealer, was handed the sentence on Wednesday after pleading guilty to multiple charges tied to the actor’s fatal overdose. The charges included three counts of distribution of ketamine, one count of distribution resulting in death or serious bodily injury, and maintaining a drug-involved premises.

Authorities say Sangha, who was reportedly known among clients as the “Ketamine Queen,” played a central role in supplying the drug that ultimately led to Perry’s death. Court documents reveal that she became aware of the actor’s interest in ketamine through an intermediary who had contact with Perry’s personal assistant.

Prosecutors detailed how Sangha allegedly offered to provide a sample of the drug, which led to a larger transaction. The assistant is said to have purchased approximately 50 vials of ketamine on behalf of the actor, highlighting what investigators described as a dangerous and illegal supply network operating behind the scenes.

The sentencing underscores growing concerns among the U.S. authorities about the misuse of ketamine, a powerful anaesthetic that has increasingly been linked to recreational abuse and high-profile overdose cases. Officials have stressed that those who distribute controlled substances outside legal and medical frameworks will face severe consequences, especially in cases resulting in death.

The case has reignited conversations about addiction, access to controlled substances, and the hidden networks that enable drug misuse, even among high-profile individuals.

See also  Eurovision Heads to Asia with New 2026 Song Contest
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *